BR112013001838A2 - formulações contendo extratos de echinacea angustifólia e zingiber officinale que são úteis na redução de inflamação e dor periférica - Google Patents

formulações contendo extratos de echinacea angustifólia e zingiber officinale que são úteis na redução de inflamação e dor periférica

Info

Publication number
BR112013001838A2
BR112013001838A2 BR112013001838A BR112013001838A BR112013001838A2 BR 112013001838 A2 BR112013001838 A2 BR 112013001838A2 BR 112013001838 A BR112013001838 A BR 112013001838A BR 112013001838 A BR112013001838 A BR 112013001838A BR 112013001838 A2 BR112013001838 A2 BR 112013001838A2
Authority
BR
Brazil
Prior art keywords
zingiber officinale
useful
echinacea angustifolia
formulations containing
reducing inflammation
Prior art date
Application number
BR112013001838A
Other languages
English (en)
Inventor
Ezio Bombardelli
Paolo Morazzoni
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43739919&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112013001838(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indena Spa filed Critical Indena Spa
Publication of BR112013001838A2 publication Critical patent/BR112013001838A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction

Abstract

formulações contendo extratos de echinacea angustifólia e zingiber officinale que são úteis na redução de inflamação e dor periférica. a presente invenção refere-se a uma combinação de extratos lipofílicos de zingiber officinale e echinacea angustifolia para o tratamento de prurido, dor periférica, estados dolorosos e inflamatórios superficiais e profundos, dor associada com espasmos musculares, dor de herpes, e radiodermatite causada por radioterapia oncológica, com ou sem infecções de fungos ou bactérias.
BR112013001838A 2010-07-26 2011-07-20 formulações contendo extratos de echinacea angustifólia e zingiber officinale que são úteis na redução de inflamação e dor periférica BR112013001838A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2010A001373A IT1401141B1 (it) 2010-07-26 2010-07-26 Formulazioni contenenti estratti di echinacea angustifolia e di zingiber officinale utili nella riduzione dell'infiammazione e del dolore periferico
PCT/EP2011/062421 WO2012013551A1 (en) 2010-07-26 2011-07-20 Formulations containing extracts of echinacea angustifolia and zingiber officinale which are useful in reducing inflammation and peripheral pain

Publications (1)

Publication Number Publication Date
BR112013001838A2 true BR112013001838A2 (pt) 2016-05-31

Family

ID=43739919

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013001838A BR112013001838A2 (pt) 2010-07-26 2011-07-20 formulações contendo extratos de echinacea angustifólia e zingiber officinale que são úteis na redução de inflamação e dor periférica

Country Status (22)

Country Link
US (2) US9283259B2 (pt)
EP (1) EP2598156B1 (pt)
JP (1) JP5996534B2 (pt)
KR (1) KR101812746B1 (pt)
CN (1) CN103096907B (pt)
AR (1) AR082342A1 (pt)
AU (1) AU2011285025B2 (pt)
BR (1) BR112013001838A2 (pt)
CA (1) CA2806428C (pt)
CL (1) CL2013000241A1 (pt)
DK (1) DK2598156T3 (pt)
ES (1) ES2477548T3 (pt)
HR (1) HRP20140583T8 (pt)
IL (1) IL224388A (pt)
IT (1) IT1401141B1 (pt)
MX (1) MX338951B (pt)
PL (1) PL2598156T3 (pt)
PT (1) PT2598156E (pt)
RU (1) RU2565436C2 (pt)
SG (1) SG187601A1 (pt)
SI (1) SI2598156T1 (pt)
WO (1) WO2012013551A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20121317A1 (it) * 2012-07-27 2014-01-28 Indena Spa Composizioni per il trattamento della fatica oncologica
KR20220125370A (ko) * 2013-03-14 2022-09-14 마리 케이 인코포레이티드 화장품 조성물들
ITMI20130807A1 (it) * 2013-05-16 2014-11-17 Indena Spa Combinazioni di estratti di serenoa repens e di estratti lipofili di zingiber officinalis e di echinacea angustifolia, loro uso e formulazioni che li contengono
AU2014373611A1 (en) * 2013-12-24 2016-07-14 Innovative Herbal Products (Aust) Pty Ltd Treatment of pain
CA2939976C (en) * 2014-02-20 2023-09-05 Indena S.P.A. Compositions containing extracts of curcuma longa and echinacea angustifolia which are useful to reduce peripheral inflammation and pain
CN103961482A (zh) * 2014-04-23 2014-08-06 湖州康企药业有限公司 一种治疗皮炎的天然药物
DE202015006894U1 (de) * 2015-08-31 2015-12-21 Dr. August Wolff Gmbh & Co. Kg Arzneimittel Zusammensetzungen enthaltend einen Extrakt aus Echinacea und Linolsäurederivate
EP3150214A1 (en) * 2015-10-01 2017-04-05 INDENA S.p.A. Compositions containing extracts of curcuma spp and zingiber officinale which are useful to reduce peripheral inflammation and pain
ITUB20161030A1 (it) * 2016-02-24 2017-08-24 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento dell’infiammazione e del dolore
ITUA20161822A1 (it) * 2016-03-18 2017-09-18 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
KR101684218B1 (ko) * 2016-04-04 2016-12-07 이경복 통증 완화를 위한 에센셜 오일
US20190117547A1 (en) * 2016-05-30 2019-04-25 Symrise Ag Cosmetic compositions comprising sclareolide
ITUA20164757A1 (it) * 2016-06-29 2017-12-29 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento dell’infiammazione e del dolore osteoarticolare e del danno cartilagineo
EP3335716A1 (en) * 2016-12-15 2018-06-20 Indena S.p.A. Process for the preparation of powder compositions
EP3607959A1 (en) * 2018-08-10 2020-02-12 Raman Mehta Formulations containing lipophilic extracts of spicy edible plants useful in controlling pain and inflammation
US11147835B1 (en) 2020-08-20 2021-10-19 Frank Kelly Reilly, III Nutritional supplement

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69020341T2 (de) 1990-07-05 1995-11-02 Indena Spa Echinacea-Extrakte, Verfahren zur Herstellung und Zubereitungen, die sie enthalten.
JP3030062B2 (ja) * 1990-07-26 2000-04-10 インデナ・ソチエタ・ペル・アチオニ エキナセア抽出物、抽出物の製造方法及びそれらを含む製剤
WO1999021007A1 (en) * 1997-10-23 1999-04-29 Pharmaprint, Inc. Pharmaceutical grade echinacea
US20010046523A1 (en) * 2000-02-25 2001-11-29 Thomas Newmark Ginger-based herbal composition for promoting health and methods of using same
US6274177B1 (en) * 2000-08-26 2001-08-14 National Science Council Method of preparing an extract potent in anti-inflammation and anti-platelet aggregation from Zingiber officinale and pharmaceutical compositions containing said extract
CN1279963C (zh) * 2001-06-07 2006-10-18 财团法人制药工业技术发展中心 从姜制备含抗发炎、抗血小板凝集或抗菌活性的有效成分的产品及方法和产品的医药组成物
US20030157185A1 (en) * 2002-02-08 2003-08-21 Lou Paradise Topical treatment of neuropathy
ITMI20021691A1 (it) * 2002-07-30 2004-01-30 Indena Spa Estratti di echinacea angustifolia
ITMI20032286A1 (it) * 2003-11-24 2005-05-25 Indena Spa Composizioni per il trattamento di dermatiti atopiche di stati allergici cutanei e dell'acne
JP5303697B2 (ja) * 2005-10-26 2013-10-02 オリザ油化株式会社 抗炎症剤
US7282224B1 (en) * 2006-06-09 2007-10-16 Guthy-Renker Corporation Pain relief composition
WO2008070783A2 (en) * 2006-12-07 2008-06-12 Herbalscience Singapore Pte. Ltd. Compositions and methods comprising zingiber species
CN101125136B (zh) * 2006-12-26 2010-06-02 广东药学院 高良姜二苯基庚烷类化合物在镇痛抗炎中的应用及其提取方法
EP2009023A1 (en) * 2007-06-04 2008-12-31 Rentschler Beteiligungs GmbH Novel peptides and their use for the treatment of edema
US7824986B2 (en) * 2008-11-05 2010-11-02 Micron Technology, Inc. Methods of forming a plurality of transistor gates, and methods of forming a plurality of transistor gates having at least two different work functions
ITMI20090049A1 (it) * 2009-01-20 2010-07-21 Indena Spa Composizioni a base di estratti lipofili di zingiber officinale e di echinacea angustifolia per la prevenzione e il trattamento del riflusso gastro-esofageo e dell'emesi indotta da chemioterapici

Also Published As

Publication number Publication date
US9283259B2 (en) 2016-03-15
JP5996534B2 (ja) 2016-09-21
IL224388A (en) 2016-05-31
WO2012013551A1 (en) 2012-02-02
MX338951B (es) 2016-05-05
SG187601A1 (en) 2013-03-28
AU2011285025B2 (en) 2014-03-20
HRP20140583T1 (hr) 2014-08-01
KR20130041137A (ko) 2013-04-24
AU2011285025A1 (en) 2013-02-07
PL2598156T3 (pl) 2014-10-31
MX2013000999A (es) 2013-03-22
IT1401141B1 (it) 2013-07-12
CA2806428A1 (en) 2012-02-02
HRP20140583T8 (hr) 2014-10-24
RU2013103334A (ru) 2014-07-27
DK2598156T3 (da) 2014-06-30
JP2013532671A (ja) 2013-08-19
EP2598156A1 (en) 2013-06-05
AR082342A1 (es) 2012-11-28
ES2477548T3 (es) 2014-07-17
ITMI20101373A1 (it) 2012-01-27
US20130266672A1 (en) 2013-10-10
US9839663B2 (en) 2017-12-12
CL2013000241A1 (es) 2013-05-03
CN103096907B (zh) 2016-06-08
RU2565436C2 (ru) 2015-10-20
EP2598156B1 (en) 2014-05-14
PT2598156E (pt) 2014-07-16
KR101812746B1 (ko) 2017-12-27
SI2598156T1 (sl) 2014-08-29
CN103096907A (zh) 2013-05-08
US20160151441A1 (en) 2016-06-02
CA2806428C (en) 2020-08-25

Similar Documents

Publication Publication Date Title
BR112013001838A2 (pt) formulações contendo extratos de echinacea angustifólia e zingiber officinale que são úteis na redução de inflamação e dor periférica
EP2563366A4 (en) USE OF PHOSPHOLIPID CONJUGATES FROM SYNTHETIC TLR7 AGONISTS
BR112015011171A2 (pt) compostos de pirrolopirimidina como inibidores da quinase
BR112015027536A2 (pt) composição compreendendo mistura de bactérias ácidas lácticas, bem como uso da referida mistura
WO2015009726A3 (en) Medical uses of cd38 agonists
CR20140108A (es) Compuesto de ciclopropanoamina
MX365427B (es) Composiciones transdermicas de ibuprofeno y metodos de uso de las mismas.
EA201690980A1 (ru) Комбинированная терапия, включающая ингибитор mdm2 и один или более дополнительных фармацевтически активных агентов, для лечения различных видов рака
BR112015005227A2 (pt) inibidores de glicosilceramida sintase
SG10201808102WA (en) Bicyclic heterocycle compounds and their uses in therapy
DOP2013000007A (es) Pirimidinadas y triazinas condensadas y su uso
CU20120161A7 (es) 5-fluoro-1h-pirazolopiridinas sustituidas
AR074777A1 (es) Proteinas de union a antigeno
ECSP12011962A (es) Tratamientos para trastornos gastrointestinales
BRPI1010861A8 (pt) métodos para tratamento de dor, inflamação ou osteoartrite, pacote e formulação farmacêutica
BR112012005044A2 (pt) composições que compreendem tramadol e celecoxib no tratamento de dor.
BR112013017953A2 (pt) Composição farmacêutica, formulação tópica, método, e, composição fotossensibilizadora
CO6710913A2 (es) Uso de ácido lipasa lisosomal para tratar la deficiencia de ácido lipasa lisosomal en pacientes
CO7141430A2 (es) Formulaciones vesiculares para uso en el tratamiento del dolor o movilidad reducida de una articulación
BR112013033759A8 (pt) Forma de dosagem unitária de um gel de base aquosa de metronidazol mucoadesivo e uso relacionado ao gel de base aquosa de metronidazol
BR112012022243A2 (pt) terapias inibidoras de autografia baseadas em tioxantona para tratar câncer
BRPI1014488A2 (pt) composições adequadas para o tratamento tópico de infecções fúngicas da pele e das unhas
BRPI0810384B8 (pt) terapia enzimática anticâncer
BR112014000634A2 (pt) métodos para tratamento de incontinência associada com atividade sexual
UY33219A (es) Cetoenoles cíclicos para terapias

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.